95.10
0.50%
0.47
Blueprint Medicines Corp Stock (BPMC) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
33.57%
96.12
|
71.96 | 56.57 | 57.57 | 63.29 |
Cost Of Revenue |
1,127%
3.191
|
0.26 | 2.782 | 2.323 | 3.175 |
Gross Profit |
29.61%
92.92
|
71.70 | 53.78 | 55.25 | 60.11 |
Operating Expenses
|
2.86%
171.75
|
176.81 | 182.76 | 183.23 | 184.32 |
Benefits Costs and Expenses |
96.28%
6.80
|
182.81 | 190.08 | 190.17 | 192.33 |
Costs And Expenses |
1.20%
174.94
|
177.07 | 185.55 | 185.55 | 187.49 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
25.01%
-78.82
|
-105.11 | -128.98 | -127.98 | -124.21 |
Net Interest Income/Expense |
14.05%
-5.895
|
-5.169 | -3.808 | -3.996 | -5.819 |
Nonoperating Income/Loss |
3,026%
168.14
|
-5.746 | -4.536 | -4.622 | -4.833 |
Income/Loss From Continuing Operations Before Tax |
180.57%
89.32
|
-110.86 | -133.52 | -132.60 | -129.04 |
Income Tax Expense/Benefit |
195.08%
0.18
|
0.061 | 0.197 | 0.19 | 0.52 |
Income/Loss From Continuing Operations After Tax |
180.36%
89.14
|
-110.92 | -133.71 | -132.79 | -129.56 |
Net Income/Loss
|
180.36%
89.14
|
-110.92 | -133.71 | -132.79 | -129.56 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
150.99%
61.58
|
-120.77 | 60.69 | 60.52 | 60.13 |
Diluted Average Shares |
56,362%
63.80
|
0.113 | 60.69 | 60.52 | 60.13 |
Basic Earnings Per Share |
179.23%
1.45
|
-1.83 | -2.20 | -2.19 | -2.15 |
Diluted Earnings Per Share |
176.92%
1.40
|
-1.82 | -2.20 | -2.19 | -2.15 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):